Patient satisfaction with virtual clinic during Coronavirus disease (COVID-19) pandemic in primary healthcare, Riyadh, Saudi Arabia

Patient satisfaction with virtual clinic during Coronavirus disease (COVID-19) pandemic in primary healthcare, Riyadh, Saudi Arabia

The novel coronavirus, formally often called COVID-19, was first reported in Wuhan, China in December of 2019. Since that point, medical providers in Saudi Arabia have tailored to the state of affairs by delivering medical care by way of virtual clinics. Therefore, the current examine aimed to evaluate sufferers’ stage of satisfaction with virtual clinics during the COVID-19 pandemic in Saudi Arabia. This cross-sectional examine was carried out amongst sufferers who had skilled virtual clinics in primary healthcare facilities in Riyadh, Saudi Arabia.
An on-line validated questionnaire was despatched to all members who had at the very least one virtual go to between March 2020 to July 2020. The information sought included demographics, stage of satisfaction and questions associated to their expertise with virtual clinics. Computed frequencies and percentages for categorical variables, and median, imply, and commonplace deviation for steady variables. Satisfaction scores have been in contrast between teams utilizing Mann-Whitney U check and Kruskal Wallis check. Disasters can have catastrophic impacts on society and are broadly labeled into pure occasions, man-made incidents, or a mix of each.
A complete of 439 sufferers accomplished the questionnaire (response fee 97.5%); 54% have been male. The members have been divided into three age teams: 18-39, 40-59, and ≥60 years. Overall stage of sufferers’ satisfaction with virtual clinic was 68.1%. Factors statistically considerably related with satisfaction included gender, age group and stage of training (post-graduate and center faculty) and being well-informed on the usage of telemedicine. Specific age teams that have been important have been 18-39 and 40-59 years; 50.2% of the males discovered telemedicine very handy, in comparison with solely 36.1% females.
Family drugs clinics have been essentially the most generally visited virtual clinics, whereas obstetrics and gynecology clinics have been the least attended virtual clinics. The lack of ability to satisfy the health-care skilled face-to-face was reported by 53.8% as a very powerful drawback. This examine exhibits a excessive stage of satisfaction with virtual clinics in Saudi Arabia during the COVID-19 pandemic regardless of the service being comparatively new in healthcare service in the nation. Our examine demonstrated that satisfaction was linked to age, gender, training and the kind of clinic used.

An Evidence-based Approach towards a Sustainable Healthcare System

Japan is essentially the most quickly growing older nation in the world, and the sustainability of its well being and social care system is a prime precedence. In order to have a sustainable healthcare system, international safety of healthcare commons by means of laws, collectively with a market mechanism based mostly on societal values, is essential. An evidence-based method is required to achieve that; nevertheless, the present methodologies for this method have main limitations, resembling the shortage of widespread healthcare targets, the retrospective nature of proof, and the uncertainty and ambiguity of the accessible information.
This opinion paper discusses the challenges in creating a sustainable system and proposes a possible option to overcome the restrictions. Myron Gittell’s 2009 ebook, Woodstock ’69: Three Days of Peace, Music, and Medical Care, is a compelling treatise referencing well being care at Woodstock. Gittell’s work partially informs this text in regards to the iconic 1969 Woodstock Music Festival. About 400,000 individuals attended the live performance, although organizers had initially deliberate for under 50,000. Helicopter surveillance previous the pageant revealed that hundreds of spectators had already arrived.
Directors realized they’d the potential for one of many “biggest human tragedies in trendy occasions” and marshaled native authorities, well being care suppliers, native townspeople, the US Army, and an eccentric outfit from New Mexico often called the Hog Farmers, whose extraordinary efforts averted public well being catastrophe. Drug overdoses offered issues however humane administration by the Hog Farmers was exquisitely profitable. Two deaths occurred and 3000 first help visits have been recorded.
One charming side of Woodstock was a movie interview with the gentleman who cleaned the transportable bogs. This 3-minute dialogue portrayed, unexpectedly and in uncommon trend, Woodstock’s sociological complexities. The launch, in 2018, of yet one more high-profile movie depicting Woodstock, and the bountiful journalistic efforts that ensued in the summer time of 2019 reminiscing upon Woodstock’s 50th anniversary, remind us of society’s abiding fascination with this occasion.
Patient satisfaction with virtual clinic during Coronavirus disease (COVID-19) pandemic in primary healthcare, Riyadh, Saudi Arabia

Delivering High-Quality, Equitable Care in India: An Ethically-Resilient Framework for Healthcare Innovation After COVID-19

 

Developing nations battle to supply high-quality, equitable care to all. Challenges of useful resource allocation ceaselessly result in moral issues of healthcare inequity. To sort out this, such creating nations regularly must implement healthcare innovation, coupled with capability constructing to make sure new methods proceed to be developed and executed. The COVID-19 pandemic has made important calls for of healthcare programs throughout the world-to present equitable healthcare to all, to make sure public well being rules are adopted, to search out novel options for beforehand unencountered healthcare challenges, and to quickly develop new therapeutics and vaccines for COVID-19.

Countries worldwide have struggled to perform these calls for, particularly the latter two, contemplating that few nations had long-standing programs in place to make sure processes for innovation have been on-going earlier than the pandemic struck. The disaster represents a essential juncture to plan for a future. This future wants to include a imaginative and prescient for the implementation of healthcare innovation, coupled with capability constructing to make sure new methods proceed to be developed and executed.

[Val5] Angiotensin II Peptide

20-abx265197
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II Substrate Peptide

20-abx265623
  • EUR 467.00
  • EUR 759.00
  • EUR 342.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1] Angiotensin II Peptide

20-abx266586
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II (Ang II) Peptide (OVA)

20-abx651045
  • EUR 272.00
  • EUR 189.00
  • EUR 606.00
  • EUR 300.00
  • EUR 230.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Angiotensin II (4-8) Peptide

20-abx265182
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II (3-8) Peptide

20-abx265183
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II (1-4) Peptide

20-abx265185
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Asn1,Val5]-Angiotensin II Peptide

20-abx266003
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1,Gly8]-Angiotensin II Peptide

20-abx266581
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Sar1,Ala8]-Angiotensin II Peptide

20-abx266583
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Sar1,Ile4,8]-Angiotensin II Peptide

20-abx266584
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

[Sar1,Thr8]-Angiotensin II Peptide

20-abx266585
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II [Sar1 Ile8] Peptide

20-abx266588
  • EUR 718.00
  • EUR 328.00
  • EUR 467.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II

H-7714.0005 5.0mg
EUR 60
Description: Sum Formula: C50H71N13O12; CAS# [4474-91-3] net

Angiotensin II

H-1705.0025 25.0mg
EUR 176
Description: Sum Formula: C50H71N13O12; CAS# [4474-91-3] net

Angiotensin II

H-1705.0100 100.0mg
EUR 466
Description: Sum Formula: C50H71N13O12; CAS# [4474-91-3] net

Angiotensin II

A1042-10 10 mg
EUR 108
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

A1042-25 25 mg
EUR 131
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

A1042-250 250 mg
EUR 630
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

A1042-5 5 mg
EUR 84
Description: Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | His-Leu) is an octapeptide that is converted from Angiotensin I (AI) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung.

Angiotensin II

4917-5MG
EUR 202

Positive control tissue section for each antibody; Based on availability INQUIRE

Control-Slides Set of 5
EUR 176

Angiotensin I / II (5-8) Peptide

20-abx265760
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin I / II (3-7) Peptide

20-abx265779
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin I / II (1-6) Peptide

20-abx265799
  • EUR 328.00
  • EUR 495.00
  • EUR 272.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1,Val5,Ala8]-Angiotensin II Peptide

20-abx266582
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Human Kinase Library II

HKIN-II 1 set
EUR 450

Human Drug Detoxication II

HDTX-II 1 set
EUR 645

Human Cytokine Primer Library II

HCA-II 1 set
EUR 450

Mouse Cytokine Primer Library II

MCA-II 1 set
EUR 450

Rat Cytokine Primer Library II

RCA-II 1 set
EUR 548

Angiotensin I / II (1-7) (Biotin) Peptide

20-abx266007
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

AT1A, Angiotensin II receptor, (225 237) Peptide

20-abx266391
  • EUR 523.00
  • EUR 871.00
  • EUR 384.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin II Type 1 Receptor Blocking Peptide

DF7592-BP 1mg
EUR 195

Human Deoxyribonuclease II (Dnase II) Control/blocking peptide # 1

DNASE21-P 100 ug
EUR 164

Mouse Deoxyribonuclease II (Dnase II) Control/blocking peptide # 2

DNASE22-P 100 ug
EUR 164

Human Colon Cancer Primer Library II

HCCP-II 1 set
EUR 548

Human DNA Repair Primer Library II

HDRL-II 1 set
EUR 548

Mouse DNA Repair Primer Library II

MDRL-II 1 set
EUR 645

Angiotensin II human

HY-13948 50mg
EUR 394

Angiotensin II Antipeptide

H-8160.0005 5.0mg
EUR 273
Description: Sum Formula: C42H62N10O12; CAS# [121379-63-3]

Angiotensin II Antipeptide

H-8160.0025 25.0mg
EUR 998
Description: Sum Formula: C42H62N10O12; CAS# [121379-63-3]

(Sar1)-Angiotensin II

H-1740.0025 25.0mg
EUR 273
Description: Sum Formula: C49H71N13O10; CAS# [51833-69-3]

(Sar1)-Angiotensin II

H-1740.0100 100.0mg
EUR 756
Description: Sum Formula: C49H71N13O10; CAS# [51833-69-3]

(Val5)-Angiotensin II

H-1750.0025 25.0mg
EUR 273
Description: Sum Formula: C49H69N13O12; CAS# [58-49-1]

(Val5)-Angiotensin II

H-1750.0100 100.0mg
EUR 756
Description: Sum Formula: C49H69N13O12; CAS# [58-49-1]

Angiotensin II Antipeptide

20-abx265974
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1] Angiotensin II

5-00293 24 x 5mg Ask for price

Angiotensin II Antipeptide

5-00686 4 x 5mg Ask for price

Angiotensin II human

5-00687 4 x 5mg Ask for price

Angiotensin II Substrate

5-00693 4 x 5mg Ask for price

Angiotensin II protein

30R-2769 5 mg
EUR 247
Description: Purified native Human Angiotensin II protein

Angiotensin II antibody

70-1089 100 ug
EUR 727
Description: Rabbit anti-human Angiotensin II antibody

Angiotensin II (Ang II) Antibody

20-abx130645
  • EUR 300.00
  • EUR 133.00
  • EUR 759.00
  • EUR 398.00
  • EUR 258.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Angiotensin II (Ang II) Antibody

20-abx131719
  • EUR 314.00
  • EUR 759.00
  • EUR 398.00
  • EUR 154.00
  • EUR 244.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug
  • Shipped within 5-7 working days.

Angiotensin II (Ang II) Antibody

20-abx101258
  • EUR 300.00
  • EUR 133.00
  • EUR 759.00
  • EUR 398.00
  • EUR 258.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-15 working days.

Angiotensin II (Ang II) Antibody

abx021123-02mg 0.2 mg
EUR 1135
  • Shipped within 5-10 working days.

Human Interferon Type II Signaling Primer Library

HIFN-II 1 set
EUR 548

Human Cancer Driver Gene II Primer Library

HCDG-II 1 set
EUR 645

Angiotensin Peptide

20-abx265534
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

[Sar1]-Angiotensin I / II (1-7) amide Peptide

20-abx266580
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 100 mg
  • 25 mg
  • 50 mg
  • Shipped within 5-10 working days.

Angiotensin II (Ang II) ELISA Kit

abx511338-96tests 96 tests
EUR 668
  • Shipped within 5-12 working days.

Mouse Hexokinase 2 (HXK-II) Control/blocking peptide

HXK23-P 100 ug
EUR 164

(Asn1,Val5)-Angiotensin II

H-6010.0025 25.0mg
EUR 321
Description: Sum Formula: C49H70N14O11; CAS# [53-73-6]

(Asn1,Val5)-Angiotensin II

H-6010.0100 100.0mg
EUR 902
Description: Sum Formula: C49H70N14O11; CAS# [53-73-6]

Angiotensin II Receptor Ligand

H-9395.0001 1.0mg
EUR 176
Description: Sum Formula: C52H69N13O11; CAS# [127060-75-7]

Angiotensin II Receptor Ligand

H-9395.0005 5.0mg
EUR 611
Description: Sum Formula: C52H69N13O11; CAS# [127060-75-7]

(Sar1,Gly8)-Angiotensin II

H-1725.0025 25.0mg
EUR 273
Description: Sum Formula: C42H65N13O10; CAS# [51887-62-8]

(Sar1,Gly8)-Angiotensin II

H-1725.0100 100.0mg
EUR 756
Description: Sum Formula: C42H65N13O10; CAS# [51887-62-8]

(Sar1,Ile8)-Angiotensin II

H-1730.0025 25.0mg
EUR 273
Description: Sum Formula: C46H73N13O10; CAS# [37827-06-8]

(Sar1,Ile8)-Angiotensin II

H-1730.0100 100.0mg
EUR 756
Description: Sum Formula: C46H73N13O10; CAS# [37827-06-8]

(Sar1,Thr8)-Angiotensin II

H-1745.0025 25.0mg
EUR 273
Description: Sum Formula: C44H69N13O11; CAS# [53632-49-8]

(Sar1,Thr8)-Angiotensin II

H-1745.0100 100.0mg
EUR 756
Description: Sum Formula: C44H69N13O11; CAS# [53632-49-8]

Angiotensin II 5-valine

HY-P0108 50mg
EUR 153

[Sar1, Ile8]-Angiotensin II

HY-P1564 50mg
EUR 497

Angiotensin II (AngII) Antibody

20-abx175396
  • EUR 411.00
  • EUR 133.00
  • EUR 1135.00
  • EUR 551.00
  • EUR 314.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug
  • Shipped within 5-7 working days.

Anti-Angiotensin II Antibody

A1588-100
EUR 338

Anti-Angiotensin II Antibody

A1588-30T
EUR 146

[Asn1, Val5]-Angiotensin II

5-00053 4 x 5mg Ask for price

[Sar1, Ala8]-Angiotensin II

5-00294 24 x 5mg Ask for price

[Sar1, Gly8]-Angiotensin II

5-00295 24 x 5mg Ask for price

[Sar1, Thr8]-Angiotensin II

5-00297 24 x 5mg Ask for price

[Val5] Angiotensin II, human

5-00373 4 x 5mg Ask for price

Angiotensin II [Sar1 Ile8]

5-00691 24 x 5mg Ask for price

Synthetic Angiotensin II (AngII)

4-SPA005Mi01
  • EUR 350.88
  • EUR 197.00
  • EUR 1040.80
  • EUR 413.60
  • EUR 727.20
  • EUR 298.00
  • EUR 2452.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
  • Uniprot ID: Inquire
  • Buffer composition: PBS, pH 7.4.
  • Form: Freeze-dried powder
  • Predicted Molecular Mass (KD): 1046.2Da
  • Isoelectric Point: 6.7
Description: Recombinant Human, Mouse, Rat Angiotensin II expressed in: E.coli

[Sar1,Ala8]-Angiotensin II

SP-100367-25 25 mg
EUR 286

[Sar1,Gly8]-Angiotensin II

SP-100368-25 25 mg
EUR 286

[Sar1,Thr8]-Angiotensin II

SP-100369-25 25 mg
EUR 286

Mouse Angiotensin converting enzyme 1 (ACE-1) control peptide # 1

ACE11-P 100 ug
EUR 164

Human Angiotensin converting enzyme 1 (ACE-1) control peptide # 2

ACE12-P 100 ug
EUR 164

Mouse Angiotensin converting enzyme 2 (ACE-2) control peptide # 1

ACE21-P 100 ug
EUR 164

Human Angiotensin converting enzyme 2 (ACE-2) control peptide # 2

ACE22-P 100 ug
EUR 164

Angiotensin I Peptide

20-abx265095
  • EUR 439.00
  • EUR 495.00
  • EUR 718.00
  • EUR 1247.00
  • EUR 328.00
  • 10 mg
  • 20 mg
  • 25 mg
  • 50 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin III Peptide

20-abx265119
  • EUR 356.00
  • EUR 537.00
  • EUR 286.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Angiotensin A Peptide

20-abx266011
  • EUR 384.00
  • EUR 592.00
  • EUR 300.00
  • 10 mg
  • 25 mg
  • 5 mg
  • Shipped within 5-10 working days.

Rat Angiotensin II (Ang II) ELISA Kit

abx575126-96tests 96 tests
EUR 668
  • Shipped within 5-12 working days.

Mouse Angiotensin II (Ang II) ELISA Kit

abx575127-96tests 96 tests
EUR 786
  • Shipped within 5-12 working days.

Angiotensin II (Ang II) (Human) ELISA Kit

E4527-100
EUR 805

Human ANG II(Angiotensin II) ELISA Kit

EH2627 96T
EUR 524.1
  • Detection range: 31.25-2000 pg/ml
  • Alias: ANG II
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml

Rat ANG II (Angiotensin II) ELISA Kit

ER1637 96T
EUR 567.6
  • Detection range: 31.25-2000 pg/ml
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 18.75pg/ml

Rabbit ANG II(Angiotensin II) ELISA Kit

ERB0006 96T
EUR 567.6
  • Detection range: 31.25-2000 pg/ml
  • Alias: ANG II
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rabbit;Sensitivity: 18.75pg/ml

Mouse Angiotensin II (Ang II) ELISA Kit

20-abx153637
  • EUR 6642.00
  • EUR 3542.00
  • EUR 825.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Rabbit Angiotensin II (Ang II) ELISA Kit

20-abx155034
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Rat Angiotensin II (Ang II) ELISA Kit

20-abx155198
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Chicken Angiotensin II (Ang II) ELISA Kit

20-abx150002
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Cow Angiotensin II (Ang II) ELISA Kit

20-abx150070
  • EUR 7645.00
  • EUR 4074.00
  • EUR 942.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Horse Angiotensin II (Ang II) ELISA Kit

20-abx150439
  • EUR 7378.00
  • EUR 3933.00
  • EUR 911.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Human Angiotensin II (Ang II) ELISA Kit

20-abx150654
  • EUR 6642.00
  • EUR 3542.00
  • EUR 825.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Rat Angiotensin II (Ang II) ELISA Kit

20-abx052349
  • EUR 7237.00
  • EUR 3855.00
  • EUR 895.00
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests
  • Shipped within 5-7 working days.

Human Angiotensin II (ANG II) CLIA Kit

abx195117-96tests 96 tests
EUR 825
  • Shipped within 5-12 working days.

Rat Angiotensin II (ANG II) CLIA Kit

abx195118-96tests 96 tests
EUR 825
  • Shipped within 5-12 working days.

Pig Angiotensin II (Ang II) ELISA Kit

abx351003-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

Monkey Angiotensin II (Ang II) ELISA Kit

abx353381-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

Sheep Angiotensin II (Ang II) ELISA Kit

abx364613-96tests 96 tests
EUR 926
  • Shipped within 5-12 working days.

Dog Angiotensin II (Ang II) ELISA Kit

abx355496-96tests 96 tests
EUR 926
  • Shipped within 5-12 working days.

Angiotensin II/III (Ang II/III) Antibody

abx411118-02mg 0.2 mg
EUR 565
  • Shipped within 1 week.

Rabbit Angiotensin II (Ang II) ELISA Kit

abx256971-96tests 96 tests
EUR 786
  • Shipped within 5-12 working days.

Human Angiotensin II (Ang II) ELISA Kit

20-abx252005
  • EUR 355.00
  • EUR 668.00
  • 24 tests
  • 96 tests
  • Shipped within 5-12 working days.

Chicken Angiotensin II (Ang II) ELISA Kit

abx250027-96tests 96 tests
EUR 754
  • Shipped within 5-12 working days.

General Ang-II/ Angiotensin II ELISA Kit

E0086Ge 1 Kit
EUR 563

Porcine angiotensin II (ANG II) ELISA Kit -

QY-E40071 96T
EUR 400

Mouse NOS-II/i-NOS Control/blocking peptide # 1

iNOS-P 100 ug
EUR 164

Mouse i-NOS/NOS-II Control/blocking peptide # 2

iNOS22-P 100 ug
EUR 164

human Topoisomerase II alpha (TOP2 alpha) Control/blocking peptide

TOP2A11-P 100 ug
EUR 164

(NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide

NANP51-P 1 mg
EUR 347

(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide

PPPP321-P 100 ug
EUR 164

Human Angiotensin II, pure (bioactive)

AT65-P-5 5 mg
EUR 286

Angiotensin I/II (5-8)

H-3846.0025 25.0mg
EUR 176
Description: Sum Formula: C26H36N6O5; CAS# [34233-50-6]

Angiotensin I/II (5-8)

H-3846.0100 100.0mg
EUR 466
Description: Sum Formula: C26H36N6O5; CAS# [34233-50-6]

(Sar1,Ile4·8)-Angiotensin II

H-6252.0005 5.0mg
EUR 273
Description: Sum Formula: C43H75N13O9; CAS# [185461-45-4] net

(Sar1,Ile4·8)-Angiotensin II

H-6252.0025 25.0mg
EUR 998
Description: Sum Formula: C43H75N13O9; CAS# [185461-45-4] net

Angiotensin I/II (3-7)

H-6965.0025 25.0mg
EUR 576
Description: Sum Formula: C31H45N7O7; CAS# [122483-84-5]

Angiotensin I/II (3-7)

H-6965.0100 100.0mg
EUR 1663
Description: Sum Formula: C31H45N7O7; CAS# [122483-84-5]

([ring-D5]Phe8)-Angiotensin II

H-7256.0001 1.0mg
EUR 113
Description: Sum Formula: C50H66D5N13O12; CAS# [1926163-73-6]

([ring-D5]Phe8)-Angiotensin II

H-7256.0005 5.0mg
EUR 360
Description: Sum Formula: C50H66D5N13O12; CAS# [1926163-73-6]

In this paper, the case of the large Indian healthcare system is utilized to explain the way it may implement this imaginative and prescient. An inclusive, ethically-resilient framework has been broadly laid out for healthcare innovation in the longer term, thereby guaranteeing success in each the short- and the long-term. The PHCPs working in rural and distant communities face further challenges when dealing with disasters and have important roles during the Prevention, Preparedness, Response, and Recovery (PPRR) phases of catastrophe administration.